Date  |
|
| Apr 19, 2021 |
9 Meters Biopharma, Inc. Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters' Program in Short Bowel Syndrome |
| Apr 12, 2021 |
9 Meters Biopharma, Inc. and Celiac Disease Foundation Announce Collaboration to Support Clinical Trial Enrollment in 9 Meters' Phase 3 CeDLara Study |
| Apr 5, 2021 |
9 Meters Biopharma Announces Closing of Offering of Common Stock |
| Mar 30, 2021 |
9 Meters Biopharma Prices Public Offering of Common Stock |
| Mar 30, 2021 |
9 Meters Biopharma Announces Proposed Public Offering of Common Stock |
| Mar 22, 2021 |
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020 |
| Mar 15, 2021 |
9 Meters Biopharma Hosting Key Opinion Leader Webinar on Short Bowel Syndrome and NM-002 Program Update |
| Mar 10, 2021 |
9 Meters Biopharma, Inc. to Participate in the following Virtual March Investor Conferences |
| Mar 9, 2021 |
9 Meters Biopharma, Inc. Announces Chief Medical Officer's Presentation at NIH's Accelerating Progress in Celiac Disease Workshop |
| Mar 1, 2021 |
9 Meters Biopharma, Inc. Appoints Michael Rice to Board of Directors |
Email Alerts
Print Page